Latecomer Merck Enters Coronavirus Vaccine Field With Themis Acquisition

Company Was First To Develop An Ebola Vaccine

 
• By Andrew McConaghie
  
Merck
Merck will acquire Themis, whose vaccine is expected to enter Phase I trials later this year
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip